Technical Analysis for OPHLF - Ono Pharmaceutical

Grade Last Price % Change Price Change
grade C 18.25 5.49% 0.9500
OPHLF closed up 5.49 percent on Monday, August 12, 2019, on 9 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical OPHLF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 5.49%
Narrow Range Bar Range Contraction 5.49%
New 52 Week Low Weakness 5.49%
Gapped Down Weakness 5.49%
New 52 Week Closing High Bullish -36.70%
Narrow Range Bar Range Contraction -36.70%
New 52 Week High Strength -36.70%
Gapped Up Strength -36.70%

Older signals for OPHLF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company's products include OPDIVO intravenous infusions for treating malignant tumor; KYPROLIS, a proteasome inhibitor for intravenous injection; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Glactiv and FORXIGA tablets for type II diabetes; Kinedak tablets to treat diabetic peripheral neuropathy; Recalbon tablets to treat osteoporosis; ORENCIA injections for rheumatoid arthritis; Rivastach patches for Alzheimer's disease treatment; Onoact injections for treating tachyarrhythmia; Staybla tablets for overactive bladder; Opalmon tablets to treat peripheral circulatory disorder; Onon capsules and dry syrups for treating bronchial asthma and allergic rhinitis; and Foipan tablets for treating chronic pancreatitis and postoperative reflux esophagitis. It is also developing products for gastric, colorectal, small and non-small cell lung, head and neck, urothelial, esophageal, ovarian, biliary tract, hematologic cancers; and hodgkin lymphoma, hepatocellular carcinoma, glioblastoma, malignant pleural mesothelioma, multiple myeloma, diffuse large B cell lymphoma, follicular lymphoma, solid tumor, central nervous system lymphoma, primary testicular lymphoma, virus positive/negative solid carcinoma, chronic myeloid leukemia, cancer anorexia/cachexia, melanoma, pheochromocytoma, acute leukemia, juvenile idiopathic arthritis, lupus nephritis, untreated rheumatoid arthritis, primary sjögren syndrome, polymyositis/dermatomyositis, chronic heart failure, tachyarrhythmia, ventricular arrhythmia, sepsis, hepatitis C, parkinson's disease, overactive bladder, osteoarthritis, sjögren syndrome, and underactive bladder. Ono Pharmaceutical Co., Ltd. has collaboration agreements with Eisai Co., Ltd. and Schrödinger Inc., Fate Therapeutics, Inc., and Merus N.V. The company was founded in 1717 and is headquartered in Osaka, Japan.
Medicine RTT Cancer Pharmaceuticals Clinical Medicine Chemotherapy Oncology Parkinson's Disease Osteoarthritis Osteoporosis Rheumatoid Arthritis Alzheimer's Disease Melanoma Hematology Multiple Myeloma Allergic Rhinitis Hepatocellular Carcinoma Sepsis Glioblastoma Hepatitis C Vomiting Lymphoma Anatomical Pathology Chronic Heart Failure Ii Diabetes Overactive Bladder Solid Tumor Sjögren Syndrome Acute Leukemia Chemotherapy Induced Nausea Chronic Pancreatitis Diabetic Peripheral Neuropathy Hematologic Cancers
Is OPHLF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 28.83
52 Week Low 17.3
Average Volume 1,070
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 22.98
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.2500
Resistance 3 (R3) 18.2500 18.2500 18.2500
Resistance 2 (R2) 18.2500 18.2500 18.2500 18.2500
Resistance 1 (R1) 18.2500 18.2500 18.2500 18.2500 18.2500
Pivot Point 18.2500 18.2500 18.2500 18.2500 18.2500
Support 1 (S1) 18.2500 18.2500 18.2500 18.2500 18.2500
Support 2 (S2) 18.2500 18.2500 18.2500 18.2500
Support 3 (S3) 18.2500 18.2500 18.2500
Support 4 (S4) 18.2500